http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31d721cc69c58f64db98a8e694fc4299
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | A. Brekken Brekken |
| name | Rolf A Brekken Rolf A. Brekken |
| given-name | Rolf A. Rolf Rolf A |
| organization-name | 1Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research and; 2Department of Pharmacology, University of Texas Southwestern Medical School, Dallas, Texas 5Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas. Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, Dallas, Texas.; Department of Pharmacology, UT Southwestern, Dallas, Texas. Division of Translational Research, Departments of Internal Medicine, Surgery, and Pharmacology, and Hamon Center for Therapeutic Oncology Research and Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9185 Advanced Imaging Research Center, Departments of Internal Medicine, Radiology, Biochemistry and Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9185 1Division of Surgical Oncology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; 2Department of Surgery, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; 7Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas. Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA; Department of Surgery and Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX 75390, USA Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery, 2Hamon Center for Therapeutic Oncology Research, 3Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; 4University of Lübeck, Lübeck, Germany; and 5Progen Pharmaceuticals Ltd., Brisbane, Queensland, Australia; Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery, 2Hamon Center for Therapeutic Oncology Research, 3Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; 4University of Lübeck, Lübeck, Germany; and 5Progen Pharmaceuticals Ltd., Brisbane, Queensland, Australia; Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery, 2Hamon Center for Therapeutic Oncology Research, 3Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; 4University of Lübeck, Lübeck, Germany; and 5Progen Pharmaceuticals Ltd., Brisbane, Queensland, Australia Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX 75390, USA. 1Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas.; 6Department of Surgery, UT Southwestern Medical Center, Dallas, Texas.; 7Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas. 1Hamon Center for Therapeutic Oncology Research-Simmons Cancer Center and Departments of; 3Pharmacology, and; 4Surgery, University of Texas Southwestern Medical Center, Dallas, Texas; and 8Departments of Surgery and Pharmacology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas; and UT Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center, Department of Surgery , Dallas , TX 75235, USA Department of Surgery, Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA; Department of Pharmacology, Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington Hamon Center for Therapeutic Oncology Research University of Texas Southwestern Medical Center Dallas Texas; Department of Surgery University of Texas Southwestern Medical Center Dallas Texas Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research; Departments of 2Pathology and 3Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; 4Department of Neurological Surgery, University of California San Francisco, San Francisco, California; and 5Department of Surgery, Ajou University School of Medicine, Suwon, Korea; Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research; Departments of 2Pathology and 3Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; 4Department of Neurological Surgery, University of California San Francisco, San Francisco, California; and 5Department of Surgery, Ajou University School of Medicine, Suwon, Korea Authors' Affiliations: 1Departments of Pharmacology and Radiation Oncology and 2Hamon Center for Therapeutic Oncology Research, Division of Surgical Oncology and Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas Authors' Affiliations: 1Department of Internal Medicine, Simmons Cancer Center; 2Department of Internal Medicine, Division of Hypothalamic Research; 3Department of Surgery, Hamon Center for Therapeutic Oncology Research, and 4Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas; Departments of 5Pathology, 6Thoracic/Head and Neck Medical Oncology, and 7Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; 8Human Oncology and Pathogenesis Program and 9Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York UT Departments of Surgery and Pharmacology and the Hamon Center for Therapeutic Oncology Research UT Southwestern Medical Center 6000 Harry Hines Blvd. MC8593 Dallas Texas 75390‐8593 Department of Surgery, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas Hamon Center for Therapeutic Oncology Research, Division of Surgical Oncology, Department of Surgery, Department of Pharmacology, UT Southwestern, Dallas, Texas. Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research, Divisions of 2Surgical Oncology, Department of Surgery, 3Hematology and Oncology, Department of Internal Medicine, and 4Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research, Divisions of 2Surgical Oncology, Department of Surgery, 3Hematology and Oncology, Department of Internal Medicine, and 4Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas; Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research, Divisions of 2Surgical Oncology, Department of Surgery, 3Hematology and Oncology, Department of Internal Medicine, and 4Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas Authors' Affiliations: 1Massachusetts General Hospital, Harvard Medical School, Boston; 2Genzyme Corporation, Framingham, Massachusetts; 3James P. Wilmot Cancer Center, University of Rochester School of Medicine, Rochester, New York; and 4Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas Division of Surgical Oncology, Department of Surgery and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA 1Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; 2Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas. From the National Research Laboratory of Vascular Biology and Department of Biological Sciences (C-H.C., Y.J.K., J.H., H-K. S., H.J.L., O-J.Y., G.Y.K.), Korea Advanced Institute of Science and Technology, Daejeon, Korea; Department of Cell Differentiation (T.M.,Y.O., T.S.), The Sakaguchi Laboratory, Keio University Internal Medicine, Tokyo, Japan; Laboratory of Liposome Research (R.A.S.), Institute of Molecular Cancer Research, University of Zurich, Switzerland; Departments of Surgery and... Authors' Affiliations: Divisions of 1Hematology-Oncology, 2Pediatric Hematology-Oncology, 3Surgical Oncology, and the 4Hamon Center for Therapeutic Oncology Research, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; 5ImClone Systems, New York, New York; Authors' Affiliations: Divisions of 1Hematology-Oncology, 2Pediatric Hematology-Oncology, 3Surgical Oncology, and the 4Hamon Center for Therapeutic Oncology Research, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas; 5ImClone Systems, New York, New York Division of Surgical Oncology, Department of Surgery; Hamon Center for Therapeutic Oncology Research, the University of Texas Southwestern Medical School, Dallas; Department of Pharmacology, the University of Texas Southwestern Medical School, Dallas, TX 75390 Hamon Center for Therapeutic Oncology and Division of Surgical Oncology Advanced Imaging Research Center, ‡Simmons Comprehensive Cancer Center, §Hamon Center for Therapeutic Oncology Research, ∥Departments of Biochemistry, ⊥Pharmacology, #Internal Medicine, and ▽Surgery, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, Texas 75390, United States Department of Surgery, University of Texas Southwestern Medical Center Dallas, Texas 75390-8852, USA ; Department of Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center Dallas, Texas 75390-8852, USA. Nancy B. and Jake L. Hamon Centre for Therapeutic Oncology Research, Departments of Surgery and Pharmacology, University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390, United States Hamon Center for Therapeutic Oncology Research and Departments of Surgery and Pharmacology and Hamon Center for Therapeutic Oncology Research, Departments of Surgery and Pharmacology Hamon Center for Therapeutic Oncology Research, Departments of Surgery and Pharmacology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas 75390, United States Hamon Center for Therapeutic Oncology Research 1 , 2 , and 3; Division of Surgical Oncology, Department of Surgery 1 , 2 , and 3; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390 1 , 2 , and 3; Hamon Center for Therapeutic Oncology Research 1 , 2 , and 3; Division of Surgical Oncology, Department of Surgery 1 , 2 , and 3; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390 1 , 2 , and 3; Hamon Center for Therapeutic Oncology Research 1 , 2 , and 3; Division of Surgical Oncology, Department of Surgery 1 , 2 , and 3; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390 1 , 2 , and 3 Division of Surgical Oncology, Department of Surgery and the Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas 75390-8593, United States 1Division of Surgical Oncology, Department of Surgery;; 2Hamon Center for Therapeutic Oncology Research; and; 3Department of Pharmacology, University of Texas Southwestern Medical School, Dallas, Texas; and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, 75390 TX, USA; Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park Rd, Dallas, TX 75390-9041, USA 3Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas. 4Departments of Surgery and Pharmacology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas Division of Surgical Oncology, Department of Surgery and Department of Pharmacology, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas 1Surgery and Hamon Center for Therapeutic Oncology Research and Departments of; 2Pharmacology, University of Texas Southwestern Medical Center; Authors' Affiliations: Departments of 1Pharmacology,2Radiation Oncology,3Biostatistics, and4Surgery, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, and5Department of Experimental Therapeutics, M. D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Pharmacology,2Radiation Oncology,3Biostatistics, and4Surgery, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center at Dallas, and5Department of Experimental Therapeutics, M. D. Anderson Cancer Center, Houston, Texas Hope Heart Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington (PAP,ADB,RAB,SEF,MDG,RBV, TNW,EHS) 1Department of Vascular Biology, Hope Heart Institute, and; 4Division of Surgical Oncology, Department of Pharmacology, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas Author's Affiliation: Hamon Center for Therapeutic Oncology Research, Division of Surgical Oncology and Departments of Surgery and Pharmacology, UT Southwestern Medical Center, Dallas, Texas Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery; 2Hamon Center for Therapeutic Oncology Research; Departments of 3Pediatrics, 4Biochemistry, 5Internal Medicine, and 6Pharmacology, University of Texas Southwestern Medical School; and 7Joyant Pharmaceuticals, Dallas, Texas; and 8Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery; 2Hamon Center for Therapeutic Oncology Research; Departments of 3Pediatrics, 4Biochemistry, 5Internal Medicine, and 6Pharmacology, University of Texas Southwestern Medical School; and 7Joyant Pharmaceuticals, Dallas, Texas; and 8Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery; 2Hamon Center for Therapeutic Oncology Research; Departments of 3Pediatrics, 4Biochemistry, 5Internal Medicine, and 6Pharmacology, University of Texas Southwestern Medical School; and 7Joyant Pharmaceuticals, Dallas, Texas; and 8Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center , Dallas, Texas, USA; Division of Surgical Oncology, Departments of Surgery and Pharmacology, University of Texas Southwestern Medical Center , Dallas, Texas, USA Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Harry Hines Blvd. Dallas, TX Division of Surgical Oncology, Department of Surgery and Pharmacology, Hamon Center for Therapeutic Oncology Research University of Texas Southwestern Medical Center Dallas Texas Hamon Center for Therapeutic Oncology Research, Departments of Surgery and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas 75390; and Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Universidad Autónoma de Madrid, Cantoblanco, E-28049 Madrid, Spain Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX; and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA 2Hamon Center for Therapeutic Oncology Research, Departments of Surgery and Pharmacology, UT Southwestern Medical Center, Dallas, Texas.; 4Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas. 1Division of Surgical Oncology, Department of Surgery and Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, Texas.; 7Department of Pharmacology, UT Southwestern Medical Center, Dallas, Texas. Departments of 1Gastroenterology, Hepatology, and Nutrition, 2Experimental Therapeutics, and 3Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; 4Lineberger Comprehensive Cancer Center and Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 5Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska; and 6Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, and Department of Pharmacology, University of Texas Southwestern Medical School, Dallas, Texas Authors' Affiliations: 1Division of Surgical Oncology, Department of Surgery, The Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas; and 2Tragara Pharmaceuticals, Inc., San Diego, California Division of Surgical Oncology; Department of Surgery and Hamon Center for Therapeutic Oncology Research; University of Texas Southwestern Medical Center; Dallas, TX USA 1Division of Surgical Oncology, Department of Surgery; 2Hamon Center for Therapeutic Oncology Research; and 3Department of Pharmacology, University of Texas Southwestern Medical School, Dallas, Texas; 1Division of Surgical Oncology, Department of Surgery; 2Hamon Center for Therapeutic Oncology Research; and 3Department of Pharmacology, University of Texas Southwestern Medical School, Dallas, Texas; 1Division of Surgical Oncology, Department of Surgery; 2Hamon Center for Therapeutic Oncology Research; and 3Department of Pharmacology, University of Texas Southwestern Medical School, Dallas, Texas 1Hamon Center for Therapeutic Oncology Research, Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.; 4Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas. 3Surgery and Department of Surgery and Hamon Center for Therapeutic Oncology ResearchUT SouthwesternDallasTXUSA 2Hamon Center for Therapeutic Oncology Research, Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.; 7Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas. Division of Surgical Oncology, Department of Surgery, Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA Departments of aPharmacology and; Surgery,; Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390 1Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.; 2Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas.; 5Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas. Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center , Dallas, Texas, USA; Department of Surgery, UT Southwestern Medical Center , Dallas, Texas, USA; Cancer Biology Graduate Program, UT Southwestern Medical Center , Dallas, Texas, USA 4Hamon Center for Therapeutic Oncology Research and Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research; Departments of 2Pharmacology, 3Internal Medicine, 4Clinical Sciences, and 5Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center; 6Joyant Pharmaceuticals Inc., Dallas, Texas; 7Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 8Zhongguancun Life Science Park, Beijing, China; Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research; Departments of 2Pharmacology, 3Internal Medicine, 4Clinical Sciences, and 5Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center; 6Joyant Pharmaceuticals Inc., Dallas, Texas; 7Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 8Zhongguancun Life Science Park, Beijing, China; Authors' Affiliations: 1Hamon Center for Therapeutic Oncology Research; Departments of 2Pharmacology, 3Internal Medicine, 4Clinical Sciences, and 5Division of Surgical Oncology, Department of Surgery, University of Texas Southwestern Medical Center; 6Joyant Pharmaceuticals Inc., Dallas, Texas; 7Department of Chemistry and Biochemistry, University of California, Los Angeles, California; and 8Zhongguancun Life Science Park, Beijing, China Hamon Center for Therapeutic Oncology and Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390; From the Department of Developmental Biology (A.L.R., R.D., N.A., R.C.R.P.) and Hamon Center for Therapeutic Oncology Research (S.P.D., R.A.B.), University of Texas Southwestern Medical Center, Dallas; and Lillehei Heart Institute (A.L.R., R.D., N.A., L.B., J.C., R.C.R.P.), Department of Medicine, University of Minnesota, Minneapolis. Division of Surgical Oncology, Department of Surgery and Hamon Center for Therapeutic Oncology Research, UT Southwestern, Dallas, Texas 75390-8593, United States Division of Surgical Oncology, Department of Surgery; Hamon Center for Therapeutic Oncology Research; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390-8593, USA Department of Pharmacology and the Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, Texas, United States 7Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, United Division of Surgical Oncology, Department of Surgery and the Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas Texas 75390-8593, United States Hamon Center for Therapeutic Oncology Research and the Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX, USA |
Incoming Links
Total number of triples: 258.